7 November 2024

31st SCI Young Chemist in Industry 2024

Organised by:

AstraZeneca, Cambridge, UK

Registration Closed

This event is no longer available for registration.

Synopsis

This event will be of interest to industrial chemists to discover what their contemporaries are working on in other companies and other areas of research, but also for academic chemists who want to find out the different challenges and focus that working in an industrial setting offers. It presents a superb opportunity for younger chemists to showcase their industrial research to an external audience. Prizes will be awarded for the best talk and runners-up. In addition, a lecture from a leading industrial chemist will conclude the proceedings. All talks will be followed by a chance to ask questions and the networking opportunity allows a possible exchange of ideas.

Attendees

This meeting is aimed at chemists working in the pharmaceutical, biotechnology or agrochemical sector and would provide them with a unique opportunity to discover what their contemporaries do in other branches of the industry. The meeting would also appeal to graduates and post-graduates with a background in organic chemistry.

Speaker

Keynote speaker: David Wilson

AstraZeneca

David is Vice President and Global Head of Oncology Discovery Chemistry & DMPK at AstraZeneca. He received his PhD from the University of Leeds and completed a postdoctoral fellowship in the US before starting his pharma career at GlaxoSmithKline. He has accumulated over 27 years’ experience of small molecule drug discovery and has held senior leadership roles at GlaxoSmithKline, Johnson & Johnson and AstraZeneca. During his career, David has worked across multiple therapeutic areas including neurosciences, infectious diseases, immunology and oncology, and has been closely involved with the discovery of numerous drug candidates that have progressed into clinical phase development. David is a is a member of the Cambridge Discovery Centre site leadership group and represents early oncology on both the UK and Cambridge leadership teams.

Programme

Thursday 7 November 2024

10:00: Registration and refreshments
10:30: Introduction and welcome
10:35: Core modifications of GSK3335103 towards orally bioavailable αvβ6 inhibitors with improved synthetic tractability
Heather Hryczanek, GSK
11:00: First scale up of a nickel-catalysed borylation at AstraZeneca
Christopher Janot, AstraZeneca
11:25: From Catalytic Hero to Product Contamination Zero – Extractive Recovery of Palladium from Reaction Mixtures
Marina Economidou, GSK
11:50: Lunch
13:15: Beyond Chemistry and DMPK: development of a biocatalytic toolkit for fragment-based drug discovery (FBDD)
Wojciech Zawodny, Astex
13:40: Process development of a 9-step synthetic route towards LOX279
Jasmine Cross, High Force Research
14:05: Automated HTE synthesis for data-rich experimentation within process development
Toby Waldron Clarke, AstraZeneca
14:30: Refreshment break
15:00: Covalent tools for essential leishmania bromodomain LdBDF5
Claudine Greenwood, GSK/University of Strathclyde
15:25: Discovery of potent and orally available antimalarial pmx inhibitors via molecular property optimisation
Komei Sakata, UCB
15:50: Progress in solving the 'druggability’ challenges of transformative oncology targets
Keynote speaker: David Wilson, AstraZeneca
16:35: Prize giving
16:45: Networking reception

SCI’s Young Chemists’ Panel are committed to promoting diversity and equality in the chemical sciences. We aim to identify high quality speakers for all our conferences with inclusivity of gender and ethnicity. Attendees from all backgrounds and ages are welcome.

Accessibility Grants

SCI accessibility grants are available to support SCI members with disabilities, long term health conditions, those who require a carer, and members who are nursing parents to attend SCI events. Download an application form to apply for a grant.

Exhibition and Sponsorship

An exhibition will take place alongside the conference for companies and related organisations who may wish to exhibit. Please click here for the pack and email conferences@soci.org letting us know which package you are interested in. Spaces are limited and will be allocated on a first-come, first-served basis

Travel

The AstraZeneca site is a 30-minute walk or a 5–10-minute bus journey. Buses run every 5-9 minutes from Cambridge station to the Addenbrookes site. For further details please see the link https://transport.cambridgeshirepeterborough-ca.gov.uk/buses/bus-timetables/ Although there is no parking available on site, delegates can drive and use the Cambridge park and ride sites: https://cambridgeparkandride.info/

Venue and Contact

Cambridge

The Discovery Centre
Cambridge Biomedical Campus
1 Francis Crick Avenue
Cambridge
CB2 0AA
UK

Conference Team

Tel: +44 (0)20 7598 1561

Email: conferences@soci.org

Fees

This is a free event. To enable us to control the number of visitors into the building, we are asking all delegates to pre-register in advance.

.All registrations will automatically receive a confirmation within 24 hours of registering for the event. Should you not receive written confirmation of your booking, please email conferences@soci.org

Become an SCI Member and save on this and future events

See Membership Options

Booking Process/Deadlines

Booking terms and conditions

CPD Info

SCI Members attending this meeting are able to claim CPD points.

Exhibitors

Organising committee

Adam Smalley, SCI / UCB
Alex Scollan, SCI / Charnwood Discovery
Fahima Idiris, SCI / Pharmaron
Giorgia Kidd, SCI / University of Dundee
Helen Jones, SCI / AstraZeneca